nodes	percent_of_prediction	percent_of_DWPC	metapath
Mebendazole—TUBA1A—Vinblastine—hematologic cancer	0.136	0.205	CbGbCtD
Mebendazole—ABCB1—hematologic cancer	0.128	1	CbGaD
Mebendazole—TUBB4B—Vinorelbine—hematologic cancer	0.0842	0.127	CbGbCtD
Mebendazole—TUBB4B—Vinblastine—hematologic cancer	0.0519	0.0782	CbGbCtD
Mebendazole—TUBB4B—Vincristine—hematologic cancer	0.051	0.0769	CbGbCtD
Mebendazole—CYP1A1—Methoxsalen—hematologic cancer	0.0244	0.0368	CbGbCtD
Mebendazole—CYP1A1—Bortezomib—hematologic cancer	0.0232	0.035	CbGbCtD
Mebendazole—CYP1A1—Daunorubicin—hematologic cancer	0.0222	0.0335	CbGbCtD
Mebendazole—CYP1A1—Thalidomide—hematologic cancer	0.0202	0.0305	CbGbCtD
Mebendazole—CYP1A1—Dacarbazine—hematologic cancer	0.0174	0.0262	CbGbCtD
Mebendazole—ABCB1—Lenalidomide—hematologic cancer	0.0148	0.0223	CbGbCtD
Mebendazole—CYP1A1—Dasatinib—hematologic cancer	0.0137	0.0206	CbGbCtD
Mebendazole—CYP3A4—Bexarotene—hematologic cancer	0.00887	0.0134	CbGbCtD
Mebendazole—ABCB1—Daunorubicin—hematologic cancer	0.00868	0.0131	CbGbCtD
Mebendazole—ABCB1—Alitretinoin—hematologic cancer	0.0085	0.0128	CbGbCtD
Mebendazole—CYP3A4—Busulfan—hematologic cancer	0.00825	0.0124	CbGbCtD
Mebendazole—CYP3A4—Lomustine—hematologic cancer	0.00825	0.0124	CbGbCtD
Mebendazole—CYP3A4—Thiotepa—hematologic cancer	0.00735	0.0111	CbGbCtD
Mebendazole—CYP1A1—Dexamethasone—hematologic cancer	0.007	0.0106	CbGbCtD
Mebendazole—ABCB1—Imatinib—hematologic cancer	0.00665	0.01	CbGbCtD
Mebendazole—ABCB1—Nilotinib—hematologic cancer	0.00604	0.00911	CbGbCtD
Mebendazole—ABCB1—Vinorelbine—hematologic cancer	0.00599	0.00903	CbGbCtD
Mebendazole—CYP3A4—Methoxsalen—hematologic cancer	0.00572	0.00862	CbGbCtD
Mebendazole—CYP3A4—Bortezomib—hematologic cancer	0.00544	0.0082	CbGbCtD
Mebendazole—ABCB1—Dasatinib—hematologic cancer	0.00534	0.00805	CbGbCtD
Mebendazole—ABCB1—Mitoxantrone—hematologic cancer	0.00528	0.00795	CbGbCtD
Mebendazole—CYP3A4—Daunorubicin—hematologic cancer	0.0052	0.00784	CbGbCtD
Mebendazole—ABCB1—Betamethasone—hematologic cancer	0.0047	0.00709	CbGbCtD
Mebendazole—ABCB1—Gemcitabine—hematologic cancer	0.00466	0.00703	CbGbCtD
Mebendazole—ABCB1—Prednisolone—hematologic cancer	0.00464	0.00699	CbGbCtD
Mebendazole—CYP3A4—Cytarabine—hematologic cancer	0.00459	0.00692	CbGbCtD
Mebendazole—CYP3A4—Teniposide—hematologic cancer	0.00452	0.00681	CbGbCtD
Mebendazole—ABCB1—Prednisone—hematologic cancer	0.00438	0.00661	CbGbCtD
Mebendazole—CYP3A4—Ifosfamide—hematologic cancer	0.00417	0.00629	CbGbCtD
Mebendazole—ABCB1—Irinotecan—hematologic cancer	0.00415	0.00626	CbGbCtD
Mebendazole—CYP3A4—Imatinib—hematologic cancer	0.00398	0.00601	CbGbCtD
Mebendazole—CYP3A4—Ruxolitinib—hematologic cancer	0.00375	0.00566	CbGbCtD
Mebendazole—ABCB1—Vinblastine—hematologic cancer	0.00369	0.00557	CbGbCtD
Mebendazole—ABCB1—Vincristine—hematologic cancer	0.00363	0.00547	CbGbCtD
Mebendazole—CYP3A4—Nilotinib—hematologic cancer	0.00362	0.00546	CbGbCtD
Mebendazole—CYP3A4—Vinorelbine—hematologic cancer	0.00359	0.00541	CbGbCtD
Mebendazole—ABCB1—Cisplatin—hematologic cancer	0.00339	0.0051	CbGbCtD
Mebendazole—ABCB1—Etoposide—hematologic cancer	0.00333	0.00502	CbGbCtD
Mebendazole—CYP3A4—Triamcinolone—hematologic cancer	0.00328	0.00495	CbGbCtD
Mebendazole—CYP3A4—Dasatinib—hematologic cancer	0.0032	0.00482	CbGbCtD
Mebendazole—CYP3A4—Mitoxantrone—hematologic cancer	0.00316	0.00477	CbGbCtD
Mebendazole—CYP3A4—Betamethasone—hematologic cancer	0.00282	0.00425	CbGbCtD
Mebendazole—CYP3A4—Prednisolone—hematologic cancer	0.00278	0.00419	CbGbCtD
Mebendazole—ABCB1—Dexamethasone—hematologic cancer	0.00274	0.00412	CbGbCtD
Mebendazole—CYP3A4—Prednisone—hematologic cancer	0.00263	0.00396	CbGbCtD
Mebendazole—CYP3A4—Irinotecan—hematologic cancer	0.00249	0.00375	CbGbCtD
Mebendazole—TUBA1A—hematopoietic system—hematologic cancer	0.00248	0.1	CbGeAlD
Mebendazole—ABCB1—Doxorubicin—hematologic cancer	0.00227	0.00342	CbGbCtD
Mebendazole—CYP3A4—Vinblastine—hematologic cancer	0.00221	0.00334	CbGbCtD
Mebendazole—ABCB1—Methotrexate—hematologic cancer	0.0022	0.00331	CbGbCtD
Mebendazole—CYP3A4—Vincristine—hematologic cancer	0.00218	0.00328	CbGbCtD
Mebendazole—CYP3A4—Etoposide—hematologic cancer	0.00199	0.00301	CbGbCtD
Mebendazole—TUBA1A—gonad—hematologic cancer	0.00188	0.0762	CbGeAlD
Mebendazole—TUBB4B—hematopoietic system—hematologic cancer	0.00165	0.0668	CbGeAlD
Mebendazole—TUBA1A—blood—hematologic cancer	0.00164	0.0664	CbGeAlD
Mebendazole—CYP3A4—Dexamethasone—hematologic cancer	0.00164	0.00247	CbGbCtD
Mebendazole—TUBA1A—bone marrow—hematologic cancer	0.00159	0.0642	CbGeAlD
Mebendazole—TUBA1A—lung—hematologic cancer	0.00144	0.0582	CbGeAlD
Mebendazole—CYP3A4—Doxorubicin—hematologic cancer	0.00136	0.00205	CbGbCtD
Mebendazole—TUBA1A—testis—hematologic cancer	0.00136	0.0549	CbGeAlD
Mebendazole—TUBB4B—gonad—hematologic cancer	0.00126	0.0508	CbGeAlD
Mebendazole—TUBB4B—blood—hematologic cancer	0.00109	0.0442	CbGeAlD
Mebendazole—TUBB4B—bone marrow—hematologic cancer	0.00106	0.0428	CbGeAlD
Mebendazole—TUBA1A—lymph node—hematologic cancer	0.000984	0.0398	CbGeAlD
Mebendazole—TUBB4B—lung—hematologic cancer	0.000959	0.0388	CbGeAlD
Mebendazole—CYP1A1—hematopoietic system—hematologic cancer	0.000924	0.0374	CbGeAlD
Mebendazole—TUBB4B—testis—hematologic cancer	0.000905	0.0366	CbGeAlD
Mebendazole—TUBA1A—Vitamin A—Alitretinoin—hematologic cancer	0.000797	0.185	CbGdCrCtD
Mebendazole—CYP3A4—hematopoietic system—hematologic cancer	0.000678	0.0274	CbGeAlD
Mebendazole—TUBB4B—lymph node—hematologic cancer	0.000656	0.0265	CbGeAlD
Mebendazole—TUBA1A—Zalcitabine—Cytarabine—hematologic cancer	0.000633	0.147	CbGdCrCtD
Mebendazole—TUBA1A—Zalcitabine—Gemcitabine—hematologic cancer	0.000633	0.147	CbGdCrCtD
Mebendazole—CYP1A1—blood—hematologic cancer	0.000612	0.0248	CbGeAlD
Mebendazole—TUBA1A—Tretinoin—Alitretinoin—hematologic cancer	0.000557	0.129	CbGdCrCtD
Mebendazole—TUBA1A—Isotretinoin—Alitretinoin—hematologic cancer	0.000557	0.129	CbGdCrCtD
Mebendazole—CYP1A1—lung—hematologic cancer	0.000537	0.0217	CbGeAlD
Mebendazole—ABCB1—hematopoietic system—hematologic cancer	0.00048	0.0194	CbGeAlD
Mebendazole—CYP3A4—blood—hematologic cancer	0.000449	0.0182	CbGeAlD
Mebendazole—CYP1A1—lymph node—hematologic cancer	0.000367	0.0149	CbGeAlD
Mebendazole—ABCB1—gonad—hematologic cancer	0.000365	0.0148	CbGeAlD
Mebendazole—Agranulocytosis—Ifosfamide—hematologic cancer	0.000326	0.00325	CcSEcCtD
Mebendazole—Hypersensitivity—Mercaptopurine—hematologic cancer	0.000324	0.00323	CcSEcCtD
Mebendazole—Urticaria—Teniposide—hematologic cancer	0.000322	0.00321	CcSEcCtD
Mebendazole—Abdominal pain—Teniposide—hematologic cancer	0.00032	0.00319	CcSEcCtD
Mebendazole—Angioedema—Lenalidomide—hematologic cancer	0.00032	0.00319	CcSEcCtD
Mebendazole—Hypersensitivity—Daunorubicin—hematologic cancer	0.000319	0.00318	CcSEcCtD
Mebendazole—Hypersensitivity—Clofarabine—hematologic cancer	0.000319	0.00318	CcSEcCtD
Mebendazole—ABCB1—blood—hematologic cancer	0.000318	0.0129	CbGeAlD
Mebendazole—Hypersensitivity—Pentostatin—hematologic cancer	0.000318	0.00317	CcSEcCtD
Mebendazole—Hepatitis—Alitretinoin—hematologic cancer	0.000317	0.00317	CcSEcCtD
Mebendazole—Hepatitis—Ifosfamide—hematologic cancer	0.000314	0.00313	CcSEcCtD
Mebendazole—Convulsion—Melphalan—hematologic cancer	0.000312	0.00311	CcSEcCtD
Mebendazole—Agranulocytosis—Mitoxantrone—hematologic cancer	0.00031	0.00309	CcSEcCtD
Mebendazole—ABCB1—bone marrow—hematologic cancer	0.000308	0.0125	CbGeAlD
Mebendazole—Gastrointestinal pain—Busulfan—hematologic cancer	0.000307	0.00306	CcSEcCtD
Mebendazole—Hypersensitivity—Idarubicin—hematologic cancer	0.000307	0.00306	CcSEcCtD
Mebendazole—Agranulocytosis—Gemcitabine—hematologic cancer	0.000302	0.00301	CcSEcCtD
Mebendazole—Convulsion—Hydroxyurea—hematologic cancer	0.000299	0.00298	CcSEcCtD
Mebendazole—Hypersensitivity—Teniposide—hematologic cancer	0.000298	0.00297	CcSEcCtD
Mebendazole—Urticaria—Busulfan—hematologic cancer	0.000298	0.00297	CcSEcCtD
Mebendazole—Hepatitis—Mitoxantrone—hematologic cancer	0.000298	0.00297	CcSEcCtD
Mebendazole—Gastrointestinal pain—Procarbazine—hematologic cancer	0.000298	0.00297	CcSEcCtD
Mebendazole—Abdominal pain—Busulfan—hematologic cancer	0.000297	0.00296	CcSEcCtD
Mebendazole—Angioedema—Bortezomib—hematologic cancer	0.000294	0.00293	CcSEcCtD
Mebendazole—Gastrointestinal pain—Bexarotene—hematologic cancer	0.000292	0.00291	CcSEcCtD
Mebendazole—Gastrointestinal pain—Dasatinib—hematologic cancer	0.000292	0.00291	CcSEcCtD
Mebendazole—Neutropenia—Etoposide—hematologic cancer	0.000289	0.00289	CcSEcCtD
Mebendazole—Urticaria—Procarbazine—hematologic cancer	0.000289	0.00288	CcSEcCtD
Mebendazole—Abdominal pain—Procarbazine—hematologic cancer	0.000288	0.00287	CcSEcCtD
Mebendazole—Angioedema—Vinorelbine—hematologic cancer	0.000287	0.00287	CcSEcCtD
Mebendazole—Rash—Methoxsalen—hematologic cancer	0.000285	0.00284	CcSEcCtD
Mebendazole—Dermatitis—Methoxsalen—hematologic cancer	0.000285	0.00284	CcSEcCtD
Mebendazole—Urticaria—Dasatinib—hematologic cancer	0.000283	0.00283	CcSEcCtD
Mebendazole—Abdominal pain—Bexarotene—hematologic cancer	0.000282	0.00281	CcSEcCtD
Mebendazole—Abdominal pain—Dasatinib—hematologic cancer	0.000282	0.00281	CcSEcCtD
Mebendazole—Convulsion—Bortezomib—hematologic cancer	0.000279	0.00278	CcSEcCtD
Mebendazole—ABCB1—lung—hematologic cancer	0.000279	0.0113	CbGeAlD
Mebendazole—Rash—Mercaptopurine—hematologic cancer	0.000277	0.00276	CcSEcCtD
Mebendazole—Dermatitis—Mercaptopurine—hematologic cancer	0.000277	0.00276	CcSEcCtD
Mebendazole—Hypersensitivity—Busulfan—hematologic cancer	0.000276	0.00276	CcSEcCtD
Mebendazole—Gastrointestinal pain—Chlorambucil—hematologic cancer	0.000276	0.00275	CcSEcCtD
Mebendazole—Rash—Clofarabine—hematologic cancer	0.000273	0.00272	CcSEcCtD
Mebendazole—Rash—Daunorubicin—hematologic cancer	0.000273	0.00272	CcSEcCtD
Mebendazole—Dermatitis—Clofarabine—hematologic cancer	0.000273	0.00272	CcSEcCtD
Mebendazole—Dermatitis—Daunorubicin—hematologic cancer	0.000273	0.00272	CcSEcCtD
Mebendazole—Rash—Anagrelide—hematologic cancer	0.000272	0.00271	CcSEcCtD
Mebendazole—Rash—Pentostatin—hematologic cancer	0.000272	0.00271	CcSEcCtD
Mebendazole—Dermatitis—Anagrelide—hematologic cancer	0.000272	0.00271	CcSEcCtD
Mebendazole—Dermatitis—Pentostatin—hematologic cancer	0.000272	0.00271	CcSEcCtD
Mebendazole—Gastrointestinal pain—Nilotinib—hematologic cancer	0.000269	0.00269	CcSEcCtD
Mebendazole—Hypersensitivity—Procarbazine—hematologic cancer	0.000268	0.00267	CcSEcCtD
Mebendazole—Gastrointestinal pain—Imatinib—hematologic cancer	0.000268	0.00267	CcSEcCtD
Mebendazole—Urticaria—Chlorambucil—hematologic cancer	0.000268	0.00267	CcSEcCtD
Mebendazole—Abdominal pain—Chlorambucil—hematologic cancer	0.000266	0.00266	CcSEcCtD
Mebendazole—Angioedema—Thalidomide—hematologic cancer	0.000265	0.00265	CcSEcCtD
Mebendazole—Gastrointestinal pain—Cladribine—hematologic cancer	0.000263	0.00263	CcSEcCtD
Mebendazole—ABCB1—testis—hematologic cancer	0.000263	0.0106	CbGeAlD
Mebendazole—Hypersensitivity—Dasatinib—hematologic cancer	0.000263	0.00262	CcSEcCtD
Mebendazole—Hypersensitivity—Bexarotene—hematologic cancer	0.000263	0.00262	CcSEcCtD
Mebendazole—Rash—Idarubicin—hematologic cancer	0.000262	0.00262	CcSEcCtD
Mebendazole—Dermatitis—Idarubicin—hematologic cancer	0.000262	0.00261	CcSEcCtD
Mebendazole—Hypersensitivity—Fludarabine—hematologic cancer	0.000262	0.00261	CcSEcCtD
Mebendazole—Urticaria—Nilotinib—hematologic cancer	0.000262	0.00261	CcSEcCtD
Mebendazole—Abdominal pain—Nilotinib—hematologic cancer	0.000261	0.0026	CcSEcCtD
Mebendazole—Urticaria—Imatinib—hematologic cancer	0.00026	0.0026	CcSEcCtD
Mebendazole—Convulsion—Thiotepa—hematologic cancer	0.00026	0.00259	CcSEcCtD
Mebendazole—Abdominal pain—Imatinib—hematologic cancer	0.000259	0.00258	CcSEcCtD
Mebendazole—Agranulocytosis—Etoposide—hematologic cancer	0.000258	0.00257	CcSEcCtD
Mebendazole—Urticaria—Cladribine—hematologic cancer	0.000256	0.00255	CcSEcCtD
Mebendazole—Rash—Teniposide—hematologic cancer	0.000255	0.00254	CcSEcCtD
Mebendazole—Dermatitis—Teniposide—hematologic cancer	0.000255	0.00254	CcSEcCtD
Mebendazole—Abdominal pain—Cladribine—hematologic cancer	0.000255	0.00254	CcSEcCtD
Mebendazole—Gastrointestinal pain—Vinblastine—hematologic cancer	0.000253	0.00252	CcSEcCtD
Mebendazole—Convulsion—Thalidomide—hematologic cancer	0.000252	0.00251	CcSEcCtD
Mebendazole—Angioedema—Ifosfamide—hematologic cancer	0.00025	0.00249	CcSEcCtD
Mebendazole—Hypersensitivity—Chlorambucil—hematologic cancer	0.000248	0.00248	CcSEcCtD
Mebendazole—Abdominal pain—Vinblastine—hematologic cancer	0.000244	0.00243	CcSEcCtD
Mebendazole—Hypersensitivity—Nilotinib—hematologic cancer	0.000243	0.00242	CcSEcCtD
Mebendazole—Convulsion—Carmustine—hematologic cancer	0.000242	0.00241	CcSEcCtD
Mebendazole—Hypersensitivity—Imatinib—hematologic cancer	0.000241	0.00241	CcSEcCtD
Mebendazole—Convulsion—Alitretinoin—hematologic cancer	0.000239	0.00239	CcSEcCtD
Mebendazole—Hypersensitivity—Cladribine—hematologic cancer	0.000237	0.00237	CcSEcCtD
Mebendazole—Convulsion—Ifosfamide—hematologic cancer	0.000237	0.00236	CcSEcCtD
Mebendazole—Rash—Busulfan—hematologic cancer	0.000236	0.00236	CcSEcCtD
Mebendazole—Dermatitis—Busulfan—hematologic cancer	0.000236	0.00236	CcSEcCtD
Mebendazole—Gastrointestinal pain—Lenalidomide—hematologic cancer	0.000234	0.00233	CcSEcCtD
Mebendazole—Urticaria—Melphalan—hematologic cancer	0.000233	0.00233	CcSEcCtD
Mebendazole—Convulsion—Vincristine—hematologic cancer	0.000231	0.0023	CcSEcCtD
Mebendazole—Rash—Procarbazine—hematologic cancer	0.000229	0.00229	CcSEcCtD
Mebendazole—Dermatitis—Procarbazine—hematologic cancer	0.000229	0.00229	CcSEcCtD
Mebendazole—Hypersensitivity—Vinblastine—hematologic cancer	0.000228	0.00227	CcSEcCtD
Mebendazole—Urticaria—Lenalidomide—hematologic cancer	0.000227	0.00226	CcSEcCtD
Mebendazole—Abdominal pain—Lenalidomide—hematologic cancer	0.000226	0.00225	CcSEcCtD
Mebendazole—Rash—Dasatinib—hematologic cancer	0.000225	0.00224	CcSEcCtD
Mebendazole—Rash—Bexarotene—hematologic cancer	0.000225	0.00224	CcSEcCtD
Mebendazole—Dermatitis—Dasatinib—hematologic cancer	0.000225	0.00224	CcSEcCtD
Mebendazole—Dermatitis—Bexarotene—hematologic cancer	0.000225	0.00224	CcSEcCtD
Mebendazole—Convulsion—Mitoxantrone—hematologic cancer	0.000225	0.00224	CcSEcCtD
Mebendazole—Rash—Fludarabine—hematologic cancer	0.000224	0.00224	CcSEcCtD
Mebendazole—Dermatitis—Fludarabine—hematologic cancer	0.000224	0.00223	CcSEcCtD
Mebendazole—Hypersensitivity—Melphalan—hematologic cancer	0.000216	0.00216	CcSEcCtD
Mebendazole—TUBA1A—Azacitidine—Pentostatin—hematologic cancer	0.000216	0.0501	CbGdCrCtD
Mebendazole—Gastrointestinal pain—Bortezomib—hematologic cancer	0.000215	0.00214	CcSEcCtD
Mebendazole—Hypersensitivity—Lenalidomide—hematologic cancer	0.00021	0.0021	CcSEcCtD
Mebendazole—Gastrointestinal pain—Vinorelbine—hematologic cancer	0.00021	0.00209	CcSEcCtD
Mebendazole—Urticaria—Bortezomib—hematologic cancer	0.000209	0.00208	CcSEcCtD
Mebendazole—Rash—Nilotinib—hematologic cancer	0.000208	0.00207	CcSEcCtD
Mebendazole—Abdominal pain—Bortezomib—hematologic cancer	0.000208	0.00207	CcSEcCtD
Mebendazole—Dermatitis—Nilotinib—hematologic cancer	0.000208	0.00207	CcSEcCtD
Mebendazole—Hypersensitivity—Hydroxyurea—hematologic cancer	0.000207	0.00207	CcSEcCtD
Mebendazole—Neutropenia—Prednisone—hematologic cancer	0.000207	0.00207	CcSEcCtD
Mebendazole—Urticaria—Bleomycin—hematologic cancer	0.000207	0.00207	CcSEcCtD
Mebendazole—Rash—Imatinib—hematologic cancer	0.000207	0.00206	CcSEcCtD
Mebendazole—Dermatitis—Imatinib—hematologic cancer	0.000206	0.00206	CcSEcCtD
Mebendazole—Convulsion—Cisplatin—hematologic cancer	0.000204	0.00203	CcSEcCtD
Mebendazole—Urticaria—Vinorelbine—hematologic cancer	0.000204	0.00203	CcSEcCtD
Mebendazole—Rash—Cladribine—hematologic cancer	0.000203	0.00202	CcSEcCtD
Mebendazole—Abdominal pain—Vinorelbine—hematologic cancer	0.000203	0.00202	CcSEcCtD
Mebendazole—Dermatitis—Cladribine—hematologic cancer	0.000203	0.00202	CcSEcCtD
Mebendazole—Gastrointestinal pain—Thiotepa—hematologic cancer	0.0002	0.002	CcSEcCtD
Mebendazole—Urticaria—Thiotepa—hematologic cancer	0.000195	0.00194	CcSEcCtD
Mebendazole—Angioedema—Prednisolone—hematologic cancer	0.000194	0.00194	CcSEcCtD
Mebendazole—Gastrointestinal pain—Thalidomide—hematologic cancer	0.000194	0.00193	CcSEcCtD
Mebendazole—Abdominal pain—Thiotepa—hematologic cancer	0.000194	0.00193	CcSEcCtD
Mebendazole—Hypersensitivity—Bortezomib—hematologic cancer	0.000194	0.00193	CcSEcCtD
Mebendazole—Hypersensitivity—Bleomycin—hematologic cancer	0.000192	0.00192	CcSEcCtD
Mebendazole—TUBA1A—Azacitidine—Clofarabine—hematologic cancer	0.000192	0.0446	CbGdCrCtD
Mebendazole—ABCB1—lymph node—hematologic cancer	0.000191	0.00772	CbGeAlD
Mebendazole—Hypersensitivity—Vinorelbine—hematologic cancer	0.000189	0.00189	CcSEcCtD
Mebendazole—Urticaria—Thalidomide—hematologic cancer	0.000188	0.00188	CcSEcCtD
Mebendazole—Abdominal pain—Thalidomide—hematologic cancer	0.000187	0.00187	CcSEcCtD
Mebendazole—Convulsion—Etoposide—hematologic cancer	0.000187	0.00186	CcSEcCtD
Mebendazole—Gastrointestinal pain—Carmustine—hematologic cancer	0.000186	0.00186	CcSEcCtD
Mebendazole—Rash—Melphalan—hematologic cancer	0.000185	0.00185	CcSEcCtD
Mebendazole—Dermatitis—Melphalan—hematologic cancer	0.000185	0.00185	CcSEcCtD
Mebendazole—Gastrointestinal pain—Alitretinoin—hematologic cancer	0.000184	0.00184	CcSEcCtD
Mebendazole—Convulsion—Prednisolone—hematologic cancer	0.000184	0.00184	CcSEcCtD
Mebendazole—Gastrointestinal pain—Ifosfamide—hematologic cancer	0.000182	0.00182	CcSEcCtD
Mebendazole—TUBA1A—Azacitidine—Nelarabine—hematologic cancer	0.000181	0.042	CbGdCrCtD
Mebendazole—Hypersensitivity—Thiotepa—hematologic cancer	0.000181	0.0018	CcSEcCtD
Mebendazole—Rash—Lenalidomide—hematologic cancer	0.00018	0.0018	CcSEcCtD
Mebendazole—Abdominal pain—Carmustine—hematologic cancer	0.00018	0.00179	CcSEcCtD
Mebendazole—Dermatitis—Lenalidomide—hematologic cancer	0.00018	0.00179	CcSEcCtD
Mebendazole—Urticaria—Alitretinoin—hematologic cancer	0.000179	0.00179	CcSEcCtD
Mebendazole—Angioedema—Triamcinolone—hematologic cancer	0.000179	0.00178	CcSEcCtD
Mebendazole—Abdominal pain—Alitretinoin—hematologic cancer	0.000178	0.00178	CcSEcCtD
Mebendazole—Gastrointestinal pain—Vincristine—hematologic cancer	0.000178	0.00177	CcSEcCtD
Mebendazole—Rash—Hydroxyurea—hematologic cancer	0.000178	0.00177	CcSEcCtD
Mebendazole—Dermatitis—Hydroxyurea—hematologic cancer	0.000177	0.00177	CcSEcCtD
Mebendazole—Urticaria—Ifosfamide—hematologic cancer	0.000177	0.00177	CcSEcCtD
Mebendazole—Abdominal pain—Ifosfamide—hematologic cancer	0.000176	0.00176	CcSEcCtD
Mebendazole—Hypersensitivity—Thalidomide—hematologic cancer	0.000175	0.00174	CcSEcCtD
Mebendazole—Neutropenia—Methotrexate—hematologic cancer	0.000173	0.00173	CcSEcCtD
Mebendazole—Gastrointestinal pain—Mitoxantrone—hematologic cancer	0.000173	0.00173	CcSEcCtD
Mebendazole—Gastrointestinal pain—Irinotecan—hematologic cancer	0.000173	0.00173	CcSEcCtD
Mebendazole—Abdominal pain—Vincristine—hematologic cancer	0.000172	0.00171	CcSEcCtD
Mebendazole—Convulsion—Triamcinolone—hematologic cancer	0.00017	0.00169	CcSEcCtD
Mebendazole—Urticaria—Mitoxantrone—hematologic cancer	0.000168	0.00168	CcSEcCtD
Mebendazole—Hypersensitivity—Carmustine—hematologic cancer	0.000168	0.00167	CcSEcCtD
Mebendazole—Abdominal pain—Mitoxantrone—hematologic cancer	0.000167	0.00167	CcSEcCtD
Mebendazole—Abdominal pain—Irinotecan—hematologic cancer	0.000167	0.00167	CcSEcCtD
Mebendazole—Hypersensitivity—Alitretinoin—hematologic cancer	0.000166	0.00166	CcSEcCtD
Mebendazole—Rash—Bortezomib—hematologic cancer	0.000166	0.00165	CcSEcCtD
Mebendazole—Dermatitis—Bortezomib—hematologic cancer	0.000166	0.00165	CcSEcCtD
Mebendazole—Rash—Bleomycin—hematologic cancer	0.000164	0.00164	CcSEcCtD
Mebendazole—Dermatitis—Bleomycin—hematologic cancer	0.000164	0.00164	CcSEcCtD
Mebendazole—Hypersensitivity—Ifosfamide—hematologic cancer	0.000164	0.00164	CcSEcCtD
Mebendazole—Neutropenia—Epirubicin—hematologic cancer	0.000162	0.00162	CcSEcCtD
Mebendazole—Angioedema—Betamethasone—hematologic cancer	0.000162	0.00162	CcSEcCtD
Mebendazole—Angioedema—Dexamethasone—hematologic cancer	0.000162	0.00162	CcSEcCtD
Mebendazole—Rash—Vinorelbine—hematologic cancer	0.000162	0.00161	CcSEcCtD
Mebendazole—Dermatitis—Vinorelbine—hematologic cancer	0.000162	0.00161	CcSEcCtD
Mebendazole—Hypersensitivity—Vincristine—hematologic cancer	0.00016	0.0016	CcSEcCtD
Mebendazole—Hypersensitivity—Mitoxantrone—hematologic cancer	0.000156	0.00155	CcSEcCtD
Mebendazole—Hypersensitivity—Irinotecan—hematologic cancer	0.000156	0.00155	CcSEcCtD
Mebendazole—Rash—Thiotepa—hematologic cancer	0.000155	0.00154	CcSEcCtD
Mebendazole—Dermatitis—Thiotepa—hematologic cancer	0.000154	0.00154	CcSEcCtD
Mebendazole—Agranulocytosis—Methotrexate—hematologic cancer	0.000154	0.00154	CcSEcCtD
Mebendazole—Convulsion—Betamethasone—hematologic cancer	0.000154	0.00153	CcSEcCtD
Mebendazole—Convulsion—Dexamethasone—hematologic cancer	0.000154	0.00153	CcSEcCtD
Mebendazole—Neutropenia—Doxorubicin—hematologic cancer	0.00015	0.0015	CcSEcCtD
Mebendazole—Rash—Thalidomide—hematologic cancer	0.000149	0.00149	CcSEcCtD
Mebendazole—Dermatitis—Thalidomide—hematologic cancer	0.000149	0.00149	CcSEcCtD
Mebendazole—Hepatitis—Methotrexate—hematologic cancer	0.000148	0.00148	CcSEcCtD
Mebendazole—Agranulocytosis—Epirubicin—hematologic cancer	0.000144	0.00144	CcSEcCtD
Mebendazole—Gastrointestinal pain—Etoposide—hematologic cancer	0.000144	0.00144	CcSEcCtD
Mebendazole—Rash—Carmustine—hematologic cancer	0.000144	0.00143	CcSEcCtD
Mebendazole—Dermatitis—Carmustine—hematologic cancer	0.000143	0.00143	CcSEcCtD
Mebendazole—Rash—Alitretinoin—hematologic cancer	0.000142	0.00142	CcSEcCtD
Mebendazole—Dermatitis—Alitretinoin—hematologic cancer	0.000142	0.00142	CcSEcCtD
Mebendazole—Hypersensitivity—Cisplatin—hematologic cancer	0.000142	0.00141	CcSEcCtD
Mebendazole—Angioedema—Prednisone—hematologic cancer	0.000141	0.00141	CcSEcCtD
Mebendazole—TUBA1A—Azacitidine—Fludarabine—hematologic cancer	0.000141	0.0328	CbGdCrCtD
Mebendazole—Rash—Ifosfamide—hematologic cancer	0.000141	0.0014	CcSEcCtD
Mebendazole—Dermatitis—Ifosfamide—hematologic cancer	0.00014	0.0014	CcSEcCtD
Mebendazole—Urticaria—Etoposide—hematologic cancer	0.00014	0.00139	CcSEcCtD
Mebendazole—Abdominal pain—Etoposide—hematologic cancer	0.000139	0.00139	CcSEcCtD
Mebendazole—Hepatitis—Epirubicin—hematologic cancer	0.000139	0.00139	CcSEcCtD
Mebendazole—Urticaria—Prednisolone—hematologic cancer	0.000138	0.00138	CcSEcCtD
Mebendazole—Rash—Vincristine—hematologic cancer	0.000137	0.00137	CcSEcCtD
Mebendazole—Dermatitis—Vincristine—hematologic cancer	0.000137	0.00137	CcSEcCtD
Mebendazole—Convulsion—Prednisone—hematologic cancer	0.000134	0.00134	CcSEcCtD
Mebendazole—Agranulocytosis—Doxorubicin—hematologic cancer	0.000134	0.00133	CcSEcCtD
Mebendazole—Rash—Mitoxantrone—hematologic cancer	0.000133	0.00133	CcSEcCtD
Mebendazole—Rash—Irinotecan—hematologic cancer	0.000133	0.00133	CcSEcCtD
Mebendazole—Dermatitis—Irinotecan—hematologic cancer	0.000133	0.00133	CcSEcCtD
Mebendazole—Dermatitis—Mitoxantrone—hematologic cancer	0.000133	0.00133	CcSEcCtD
Mebendazole—TUBA1A—Azacitidine—Cytarabine—hematologic cancer	0.000133	0.0309	CbGdCrCtD
Mebendazole—TUBA1A—Azacitidine—Gemcitabine—hematologic cancer	0.000133	0.0309	CbGdCrCtD
Mebendazole—Rash—Gemcitabine—hematologic cancer	0.00013	0.0013	CcSEcCtD
Mebendazole—Dermatitis—Gemcitabine—hematologic cancer	0.00013	0.0013	CcSEcCtD
Mebendazole—TUBA1A—Azacitidine—Cladribine—hematologic cancer	0.00013	0.0302	CbGdCrCtD
Mebendazole—Hypersensitivity—Etoposide—hematologic cancer	0.00013	0.00129	CcSEcCtD
Mebendazole—Hepatitis—Doxorubicin—hematologic cancer	0.000129	0.00128	CcSEcCtD
Mebendazole—Hypersensitivity—Prednisolone—hematologic cancer	0.000128	0.00128	CcSEcCtD
Mebendazole—Urticaria—Triamcinolone—hematologic cancer	0.000127	0.00126	CcSEcCtD
Mebendazole—Rash—Cisplatin—hematologic cancer	0.000121	0.00121	CcSEcCtD
Mebendazole—Dermatitis—Cisplatin—hematologic cancer	0.000121	0.00121	CcSEcCtD
Mebendazole—Gastrointestinal pain—Dexamethasone—hematologic cancer	0.000118	0.00118	CcSEcCtD
Mebendazole—Gastrointestinal pain—Betamethasone—hematologic cancer	0.000118	0.00118	CcSEcCtD
Mebendazole—Hypersensitivity—Triamcinolone—hematologic cancer	0.000118	0.00117	CcSEcCtD
Mebendazole—Urticaria—Dexamethasone—hematologic cancer	0.000115	0.00115	CcSEcCtD
Mebendazole—Urticaria—Betamethasone—hematologic cancer	0.000115	0.00115	CcSEcCtD
Mebendazole—Abdominal pain—Dexamethasone—hematologic cancer	0.000115	0.00114	CcSEcCtD
Mebendazole—Abdominal pain—Betamethasone—hematologic cancer	0.000115	0.00114	CcSEcCtD
Mebendazole—Convulsion—Methotrexate—hematologic cancer	0.000112	0.00112	CcSEcCtD
Mebendazole—Rash—Etoposide—hematologic cancer	0.000111	0.00111	CcSEcCtD
Mebendazole—Dermatitis—Etoposide—hematologic cancer	0.000111	0.00111	CcSEcCtD
Mebendazole—Rash—Prednisolone—hematologic cancer	0.000109	0.00109	CcSEcCtD
Mebendazole—Dermatitis—Prednisolone—hematologic cancer	0.000109	0.00109	CcSEcCtD
Mebendazole—Convulsion—Epirubicin—hematologic cancer	0.000105	0.00104	CcSEcCtD
Mebendazole—Gastrointestinal pain—Prednisone—hematologic cancer	0.000103	0.00103	CcSEcCtD
Mebendazole—Rash—Triamcinolone—hematologic cancer	0.000101	0.001	CcSEcCtD
Mebendazole—Dermatitis—Triamcinolone—hematologic cancer	0.000101	0.001	CcSEcCtD
Mebendazole—Urticaria—Prednisone—hematologic cancer	0.0001	0.001	CcSEcCtD
Mebendazole—Abdominal pain—Prednisone—hematologic cancer	9.97e-05	0.000995	CcSEcCtD
Mebendazole—Convulsion—Doxorubicin—hematologic cancer	9.69e-05	0.000967	CcSEcCtD
Mebendazole—Hypersensitivity—Prednisone—hematologic cancer	9.3e-05	0.000927	CcSEcCtD
Mebendazole—Rash—Betamethasone—hematologic cancer	9.14e-05	0.000911	CcSEcCtD
Mebendazole—Rash—Dexamethasone—hematologic cancer	9.14e-05	0.000911	CcSEcCtD
Mebendazole—Dermatitis—Dexamethasone—hematologic cancer	9.13e-05	0.00091	CcSEcCtD
Mebendazole—Dermatitis—Betamethasone—hematologic cancer	9.13e-05	0.00091	CcSEcCtD
Mebendazole—Gastrointestinal pain—Methotrexate—hematologic cancer	8.62e-05	0.00086	CcSEcCtD
Mebendazole—Urticaria—Methotrexate—hematologic cancer	8.38e-05	0.000835	CcSEcCtD
Mebendazole—Abdominal pain—Methotrexate—hematologic cancer	8.34e-05	0.000831	CcSEcCtD
Mebendazole—Gastrointestinal pain—Epirubicin—hematologic cancer	8.07e-05	0.000805	CcSEcCtD
Mebendazole—Rash—Prednisone—hematologic cancer	7.96e-05	0.000793	CcSEcCtD
Mebendazole—Dermatitis—Prednisone—hematologic cancer	7.95e-05	0.000793	CcSEcCtD
Mebendazole—Urticaria—Epirubicin—hematologic cancer	7.84e-05	0.000782	CcSEcCtD
Mebendazole—Abdominal pain—Epirubicin—hematologic cancer	7.8e-05	0.000778	CcSEcCtD
Mebendazole—Hypersensitivity—Methotrexate—hematologic cancer	7.77e-05	0.000775	CcSEcCtD
Mebendazole—Gastrointestinal pain—Doxorubicin—hematologic cancer	7.47e-05	0.000745	CcSEcCtD
Mebendazole—Hypersensitivity—Epirubicin—hematologic cancer	7.27e-05	0.000725	CcSEcCtD
Mebendazole—Urticaria—Doxorubicin—hematologic cancer	7.25e-05	0.000723	CcSEcCtD
Mebendazole—Abdominal pain—Doxorubicin—hematologic cancer	7.22e-05	0.00072	CcSEcCtD
Mebendazole—Hypersensitivity—Doxorubicin—hematologic cancer	6.73e-05	0.000671	CcSEcCtD
Mebendazole—Rash—Methotrexate—hematologic cancer	6.65e-05	0.000663	CcSEcCtD
Mebendazole—Dermatitis—Methotrexate—hematologic cancer	6.64e-05	0.000662	CcSEcCtD
Mebendazole—Rash—Epirubicin—hematologic cancer	6.22e-05	0.00062	CcSEcCtD
Mebendazole—Dermatitis—Epirubicin—hematologic cancer	6.22e-05	0.00062	CcSEcCtD
Mebendazole—Rash—Doxorubicin—hematologic cancer	5.76e-05	0.000574	CcSEcCtD
Mebendazole—Dermatitis—Doxorubicin—hematologic cancer	5.75e-05	0.000574	CcSEcCtD
Mebendazole—ABCB1—Metabolism—GMPS—hematologic cancer	2.08e-05	0.00026	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—FTCD—hematologic cancer	2.08e-05	0.00026	CbGpPWpGaD
Mebendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CREBBP—hematologic cancer	2.07e-05	0.00026	CbGpPWpGaD
Mebendazole—ABCB1—Allograft Rejection—VEGFA—hematologic cancer	2.06e-05	0.000258	CbGpPWpGaD
Mebendazole—TUBB4B—Transmembrane transport of small molecules—CREBBP—hematologic cancer	2.06e-05	0.000258	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—hematologic cancer	2.05e-05	0.000257	CbGpPWpGaD
Mebendazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—hematologic cancer	2.05e-05	0.000257	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	2.03e-05	0.000255	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—HDC—hematologic cancer	1.97e-05	0.000247	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—CDKN2A—hematologic cancer	1.97e-05	0.000247	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—CDKN1B—hematologic cancer	1.95e-05	0.000244	CbGpPWpGaD
Mebendazole—TUBB4B—Transmembrane transport of small molecules—ALB—hematologic cancer	1.93e-05	0.000242	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—hematologic cancer	1.91e-05	0.00024	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—MDM2—hematologic cancer	1.91e-05	0.000239	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—SMPD3—hematologic cancer	1.9e-05	0.000238	CbGpPWpGaD
Mebendazole—ABCB1—Allograft Rejection—TGFB1—hematologic cancer	1.89e-05	0.000237	CbGpPWpGaD
Mebendazole—TUBB4B—Metabolism of proteins—CCL2—hematologic cancer	1.88e-05	0.000236	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—CCND1—hematologic cancer	1.86e-05	0.000233	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—ABCC3—hematologic cancer	1.84e-05	0.000231	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	1.84e-05	0.00023	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK14—hematologic cancer	1.83e-05	0.00023	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—hematologic cancer	1.81e-05	0.000228	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—TP53—hematologic cancer	1.81e-05	0.000227	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—hematologic cancer	1.81e-05	0.000227	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—CDA—hematologic cancer	1.8e-05	0.000226	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—hematologic cancer	1.8e-05	0.000226	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—CDKN1A—hematologic cancer	1.8e-05	0.000225	CbGpPWpGaD
Mebendazole—ABCB1—Allograft Rejection—TNF—hematologic cancer	1.77e-05	0.000222	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—hematologic cancer	1.76e-05	0.00022	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—hematologic cancer	1.76e-05	0.00022	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—CDKN1B—hematologic cancer	1.74e-05	0.000218	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—PC—hematologic cancer	1.74e-05	0.000218	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—EP300—hematologic cancer	1.71e-05	0.000215	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	1.68e-05	0.000211	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—GBA—hematologic cancer	1.68e-05	0.00021	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—SLC35B2—hematologic cancer	1.68e-05	0.00021	CbGpPWpGaD
Mebendazole—CYP3A4—Biological oxidations—GSTP1—hematologic cancer	1.67e-05	0.000209	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—CCND1—hematologic cancer	1.66e-05	0.000208	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—B3GAT1—hematologic cancer	1.66e-05	0.000208	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—DCK—hematologic cancer	1.66e-05	0.000208	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—ASNS—hematologic cancer	1.66e-05	0.000208	CbGpPWpGaD
Mebendazole—CYP3A4—Metapathway biotransformation—GSTP1—hematologic cancer	1.65e-05	0.000207	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CREB1—hematologic cancer	1.62e-05	0.000203	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—CDKN1A—hematologic cancer	1.61e-05	0.000202	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—NUP98—hematologic cancer	1.59e-05	0.000199	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—hematologic cancer	1.58e-05	0.000199	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—hematologic cancer	1.58e-05	0.000198	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—HDC—hematologic cancer	1.57e-05	0.000197	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—ADCY7—hematologic cancer	1.54e-05	0.000193	CbGpPWpGaD
Mebendazole—CYP3A4—Biological oxidations—GSTM1—hematologic cancer	1.53e-05	0.000192	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—MAPK3—hematologic cancer	1.53e-05	0.000192	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—MTAP—hematologic cancer	1.53e-05	0.000192	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—NUP214—hematologic cancer	1.53e-05	0.000192	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—EP300—hematologic cancer	1.53e-05	0.000192	CbGpPWpGaD
Mebendazole—ABCB1—HIF-1-alpha transcription factor network—AKT1—hematologic cancer	1.52e-05	0.00019	CbGpPWpGaD
Mebendazole—CYP3A4—Metapathway biotransformation—GSTM1—hematologic cancer	1.51e-05	0.00019	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—MAP2K1—hematologic cancer	1.51e-05	0.000189	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—ABCG2—hematologic cancer	1.5e-05	0.000188	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—MYC—hematologic cancer	1.49e-05	0.000187	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—CDA—hematologic cancer	1.44e-05	0.000181	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—hematologic cancer	1.43e-05	0.00018	CbGpPWpGaD
Mebendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—hematologic cancer	1.41e-05	0.000177	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PC—hematologic cancer	1.39e-05	0.000174	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—MAPK3—hematologic cancer	1.37e-05	0.000172	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—FHL2—hematologic cancer	1.37e-05	0.000171	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—hematologic cancer	1.36e-05	0.00017	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—AGRN—hematologic cancer	1.34e-05	0.000168	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—hematologic cancer	1.34e-05	0.000168	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—GBA—hematologic cancer	1.34e-05	0.000168	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—SLC35B2—hematologic cancer	1.34e-05	0.000168	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—TFRC—hematologic cancer	1.34e-05	0.000168	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—MYC—hematologic cancer	1.33e-05	0.000167	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PHYH—hematologic cancer	1.28e-05	0.00016	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—GMPS—hematologic cancer	1.28e-05	0.00016	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—FTCD—hematologic cancer	1.28e-05	0.00016	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—HMMR—hematologic cancer	1.27e-05	0.000159	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—IDH2—hematologic cancer	1.27e-05	0.000159	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—MTAP—hematologic cancer	1.22e-05	0.000153	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—hematologic cancer	1.22e-05	0.000153	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—hematologic cancer	1.2e-05	0.00015	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	1.2e-05	0.00015	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—ARNTL—hematologic cancer	1.19e-05	0.00015	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—SMPD3—hematologic cancer	1.17e-05	0.000147	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—hematologic cancer	1.17e-05	0.000146	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—hematologic cancer	1.16e-05	0.000146	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—ACP5—hematologic cancer	1.16e-05	0.000146	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—CA9—hematologic cancer	1.16e-05	0.000146	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—NCOR2—hematologic cancer	1.15e-05	0.000144	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—hematologic cancer	1.13e-05	0.000142	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—hematologic cancer	1.13e-05	0.000141	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—CYCS—hematologic cancer	1.12e-05	0.000141	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—hematologic cancer	1.1e-05	0.000138	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—TP53—hematologic cancer	1.09e-05	0.000137	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—IDH1—hematologic cancer	1.09e-05	0.000137	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—FHL2—hematologic cancer	1.09e-05	0.000137	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—TXN—hematologic cancer	1.08e-05	0.000135	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—ABCC3—hematologic cancer	1.08e-05	0.000135	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—GSTO1—hematologic cancer	1.08e-05	0.000135	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—hematologic cancer	1.07e-05	0.000135	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—AGRN—hematologic cancer	1.07e-05	0.000134	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—SPHK1—hematologic cancer	1.06e-05	0.000133	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—hematologic cancer	1.04e-05	0.000131	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—ASNS—hematologic cancer	1.02e-05	0.000128	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—DCK—hematologic cancer	1.02e-05	0.000128	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—B3GAT1—hematologic cancer	1.02e-05	0.000128	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—hematologic cancer	1.02e-05	0.000128	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—UGT1A1—hematologic cancer	1.02e-05	0.000127	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—IDH2—hematologic cancer	1.01e-05	0.000127	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—HMMR—hematologic cancer	1.01e-05	0.000127	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—CRABP1—hematologic cancer	9.88e-06	0.000124	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—SLC22A1—hematologic cancer	9.88e-06	0.000124	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—HDC—hematologic cancer	9.7e-06	0.000122	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—ALOX5—hematologic cancer	9.63e-06	0.000121	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—hematologic cancer	9.62e-06	0.000121	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—ARNTL—hematologic cancer	9.54e-06	0.00012	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—hematologic cancer	9.36e-06	0.000117	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—hematologic cancer	9.34e-06	0.000117	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—NUP98—hematologic cancer	9.32e-06	0.000117	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—CA9—hematologic cancer	9.28e-06	0.000116	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—ACP5—hematologic cancer	9.28e-06	0.000116	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—NCOR2—hematologic cancer	9.16e-06	0.000115	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—NCOA3—hematologic cancer	9.05e-06	0.000113	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—ADCY7—hematologic cancer	9.05e-06	0.000113	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—NUP214—hematologic cancer	8.99e-06	0.000113	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	8.89e-06	0.000111	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—CDA—hematologic cancer	8.87e-06	0.000111	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—MTR—hematologic cancer	8.8e-06	0.00011	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—ABCG2—hematologic cancer	8.8e-06	0.00011	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—IDH1—hematologic cancer	8.72e-06	0.000109	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	8.72e-06	0.000109	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	8.65e-06	0.000108	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—ENO2—hematologic cancer	8.63e-06	0.000108	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—ABCC3—hematologic cancer	8.63e-06	0.000108	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—GSTO1—hematologic cancer	8.63e-06	0.000108	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—TXN—hematologic cancer	8.63e-06	0.000108	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PC—hematologic cancer	8.54e-06	0.000107	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—SPHK1—hematologic cancer	8.44e-06	0.000106	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—GSTT1—hematologic cancer	8.37e-06	0.000105	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—SLC35B2—hematologic cancer	8.25e-06	0.000103	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—GBA—hematologic cancer	8.25e-06	0.000103	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	8.25e-06	0.000103	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—SDC1—hematologic cancer	8.18e-06	0.000103	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—UGT1A1—hematologic cancer	8.11e-06	0.000102	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	7.95e-06	9.96e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—CRABP1—hematologic cancer	7.89e-06	9.89e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—SLC22A1—hematologic cancer	7.89e-06	9.89e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	7.82e-06	9.8e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	7.72e-06	9.68e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—ALOX5—hematologic cancer	7.69e-06	9.64e-05	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	7.69e-06	9.64e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—MTAP—hematologic cancer	7.54e-06	9.46e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—NUP98—hematologic cancer	7.45e-06	9.34e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	7.38e-06	9.26e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—ADCY7—hematologic cancer	7.23e-06	9.06e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—NCOA3—hematologic cancer	7.23e-06	9.06e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—NUP214—hematologic cancer	7.18e-06	9e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—ABCG2—hematologic cancer	7.03e-06	8.82e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—MTR—hematologic cancer	7.03e-06	8.82e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—NQO1—hematologic cancer	6.96e-06	8.72e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—CD44—hematologic cancer	6.96e-06	8.72e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—ENO2—hematologic cancer	6.9e-06	8.65e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	6.81e-06	8.54e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—FHL2—hematologic cancer	6.72e-06	8.43e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—GSTT1—hematologic cancer	6.69e-06	8.39e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—AGRN—hematologic cancer	6.59e-06	8.27e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—CYCS—hematologic cancer	6.59e-06	8.26e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—HSP90AA1—hematologic cancer	6.54e-06	8.2e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—SDC1—hematologic cancer	6.54e-06	8.2e-05	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	6.49e-06	8.14e-05	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	6.26e-06	7.85e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—IDH2—hematologic cancer	6.25e-06	7.84e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—HMMR—hematologic cancer	6.25e-06	7.84e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	5.89e-06	7.38e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—ARNTL—hematologic cancer	5.88e-06	7.37e-05	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—ALB—hematologic cancer	5.86e-06	7.35e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—GSTP1—hematologic cancer	5.8e-06	7.28e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—ACP5—hematologic cancer	5.72e-06	7.17e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—CA9—hematologic cancer	5.72e-06	7.17e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—NCOR2—hematologic cancer	5.64e-06	7.07e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	5.62e-06	7.04e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—NQO1—hematologic cancer	5.56e-06	6.97e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—CD44—hematologic cancer	5.56e-06	6.97e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—ABCB1—hematologic cancer	5.49e-06	6.89e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—IDH1—hematologic cancer	5.37e-06	6.74e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—GSTM1—hematologic cancer	5.33e-06	6.69e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—NCOR1—hematologic cancer	5.33e-06	6.69e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—GSTO1—hematologic cancer	5.31e-06	6.66e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—ABCC3—hematologic cancer	5.31e-06	6.66e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—TXN—hematologic cancer	5.31e-06	6.66e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—CYCS—hematologic cancer	5.26e-06	6.59e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—HSP90AA1—hematologic cancer	5.23e-06	6.55e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—SPHK1—hematologic cancer	5.2e-06	6.52e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—UGT1A1—hematologic cancer	5e-06	6.26e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—SLC22A1—hematologic cancer	4.86e-06	6.09e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—CRABP1—hematologic cancer	4.86e-06	6.09e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—ALOX5—hematologic cancer	4.74e-06	5.94e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—MTHFR—hematologic cancer	4.71e-06	5.91e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—GSTP1—hematologic cancer	4.64e-06	5.81e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—NUP98—hematologic cancer	4.59e-06	5.75e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—ADCY7—hematologic cancer	4.45e-06	5.58e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—NCOA3—hematologic cancer	4.45e-06	5.58e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—NUP214—hematologic cancer	4.42e-06	5.54e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—ABCG2—hematologic cancer	4.33e-06	5.43e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—MTR—hematologic cancer	4.33e-06	5.43e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—GSTM1—hematologic cancer	4.26e-06	5.34e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—NCOR1—hematologic cancer	4.26e-06	5.34e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—ENO2—hematologic cancer	4.25e-06	5.33e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	4.15e-06	5.21e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—GSTT1—hematologic cancer	4.12e-06	5.17e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—SDC1—hematologic cancer	4.03e-06	5.05e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—PIK3CG—hematologic cancer	3.96e-06	4.97e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—MTHFR—hematologic cancer	3.77e-06	4.72e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—CREBBP—hematologic cancer	3.67e-06	4.6e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—PIK3CD—hematologic cancer	3.48e-06	4.37e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—ALB—hematologic cancer	3.44e-06	4.31e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—NQO1—hematologic cancer	3.42e-06	4.29e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—CD44—hematologic cancer	3.42e-06	4.29e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—PIK3R1—hematologic cancer	3.29e-06	4.12e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—CYCS—hematologic cancer	3.24e-06	4.06e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	3.22e-06	4.04e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PIK3CG—hematologic cancer	3.16e-06	3.97e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—PIK3CB—hematologic cancer	3.03e-06	3.8e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—CREBBP—hematologic cancer	2.93e-06	3.68e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—GSTP1—hematologic cancer	2.86e-06	3.58e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PIK3CD—hematologic cancer	2.78e-06	3.49e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—ALB—hematologic cancer	2.75e-06	3.44e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—ABCB1—hematologic cancer	2.7e-06	3.39e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PIK3R1—hematologic cancer	2.63e-06	3.29e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—NCOR1—hematologic cancer	2.62e-06	3.29e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—GSTM1—hematologic cancer	2.62e-06	3.29e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—PTEN—hematologic cancer	2.62e-06	3.29e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—EP300—hematologic cancer	2.5e-06	3.14e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PIK3CB—hematologic cancer	2.42e-06	3.04e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—MTHFR—hematologic cancer	2.32e-06	2.91e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PTEN—hematologic cancer	2.09e-06	2.63e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—EP300—hematologic cancer	2e-06	2.5e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.95e-06	2.44e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—PIK3CA—hematologic cancer	1.85e-06	2.32e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.81e-06	2.27e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.71e-06	2.15e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—ALB—hematologic cancer	1.69e-06	2.12e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.62e-06	2.03e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—AKT1—hematologic cancer	1.51e-06	1.89e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.49e-06	1.87e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PIK3CA—hematologic cancer	1.48e-06	1.85e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PTEN—hematologic cancer	1.29e-06	1.62e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—EP300—hematologic cancer	1.23e-06	1.54e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—AKT1—hematologic cancer	1.21e-06	1.51e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PIK3CA—hematologic cancer	9.1e-07	1.14e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—AKT1—hematologic cancer	7.44e-07	9.32e-06	CbGpPWpGaD
